Literature DB >> 25132577

Virtual reconstruction and geometric morphometrics as tools for paleopathology: a new approach to study rare developmental disorders of the skeleton.

Marco Milella1, Christoph P E Zollikofer, Marcia S Ponce de León.   

Abstract

Survey studies of osteoarchaeological collections occasionally yield specimens exhibiting rare skeletal developmental disorders. Beyond paleopathological diagnosis, however, it is often difficult to gain insight into the processes, mechanisms, and consequences of the pathology, notably because archaeological specimens are often fragmentary. Here, we propose a combination of virtual reconstruction (VR) and geometric morphometrics (GM) to address these issues. As an example, we use VR to reconstruct the only known archaeological specimen exhibiting persistence of the pelvic triradiate cartilage and compare it via GM with a set of healthy pelvises representing both sexes and different ontogenetic stages. Our results evidence (i) a marked deviation of the pathological pelvis from the adult mean shape, (ii) the retention of typical male features, and (iii) the retention of a paedomorphic ratio between iliac and ischiopubic size. Altogether, such data offer new insights into the modularity and integration of pelvic ontogeny, while at the same time demonstrating the usefulness of a combined VR/GM approach as complement to classical methods of paleopathology.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  geometric morphometrics; growth disorders; middle ages; triradiate cartilage; virtual reconstruction

Mesh:

Year:  2014        PMID: 25132577     DOI: 10.1002/ar.23020

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  1 in total

1.  ArtiFacts: Femoroacetabular Impingement-A New Pathology?

Authors:  Corinne A Zurmühle; Marco Milella; Simon D Steppacher; Markus S Hanke; Christoph E Albers; Moritz Tannast
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.